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Actin polymerization and dynamics are involved in
a wide range of cellular processes such as cell divi-
sion andmigration of tumor cells. At sites of cell lysis,
such as those occurring during a stroke or inflamma-
tory lung diseases, actin is released into the serum
where it polymerizes, leading to problems with clot
dissolution and sputum viscosity. Therefore, drugs
that target these actin-mediated processes may
provide one mechanism to treat these conditions.
Marine-organism-derivedmacrolides, such as reidis-
pongiolide A, can bind to, sever, and inhibit polymer-
ization of actin. Our studies show that the function of
these complex macrolides resides in their tail region,
whereas the head group stabilizes the actin-drug
complex. Synthetic compounds derived from this
tail region could therefore be used as a mimetic of
the natural product, providing a range of designer
compounds to treat actin-associated diseases or as
probes to study actin polymerization.
INTRODUCTION
Spatiotemporal regulation of actin filament dynamics is required
for essential cell processes, including motility, endocytosis, cy-
tokinesis, and establishing cell-cell and cell-substrate contacts
(Westphal et al., 1997). Therefore, drugs that block the regulation
of actin filament dynamics within tumor cells or cells infected
with Listeria and related pathogens could prove useful in treating
cancer and diseased states (Fenteany and Zhu 2003). Further-
more, cell lysis associated with stroke, malaria (Smith et al.,
1988), and necrosis increases plasma actin, which can polymer-
ize close to the site of the wound impeding clot dissolution (Had-
dad et al., 1990). The capacity of plasma gelsolin to neutralize
actin filaments in the serum is very limited and often over-
whelmed following a serious stroke (Mounzer et al., 1999). There-
fore, a small molecule mimetic of plasma gelsolin would serve as
a powerful drug to control plasma actin.
Marine-organism-derived macrolides, including ulapualide A
(Roesener and Scheuer, 1986), kabiramide C (Petchprayoon
et al., 2006; Tanaka et al., 2003), and reidispongiolide A (1) (Fig-
ure 1) (D’Auria et al., 1994), hereafter referred to as reidispongio-
lide, exert their potent cytotoxicity by causing dysfunctional reg-
ulation of actin filament dynamics in cells (Tanaka et al., 2003;Chemistry & Biology 1Yeung and Paterson, 2002). The structural basis for the severing
and (+)-end-capping activities of actin-targeting macrolides was
established through biochemical and high-resolution structural
studies (Allingham et al., 2005; Klenchin et al., 2003; Petch-
prayoon et al., 2006; Tanaka et al., 2003). Reidispongiolide and
related macrolides form stable complexes with actin, having dis-
sociation constants in the nanomolar range. In vitro and in vivo
studies showed that macrolide-actin complexes reduce free
G-actin to below the critical concentration, block extension of
the (+)-end of the filament, while the free macrolide can also
bind to and sever actin filaments (Tanaka et al., 2003). In living
cells, the combined effects of these interactions leads to a cessa-
tion of new filament growth and a disruption of existing filaments
and is accompanied by a loss of motility, breakdown of adherens
junctions, polyploidy, and ultimately apoptosis (Tanaka et al.,
2003).
Both the capping and severing activities of reidispongiolide
(Figure 1) are mediated through hydrophobic interactions of
the macrolide ring at the entrance of the cleft that forms at the
interface of actin subdomains-1 (SD1) and -3 (SD3) and the tail
region with residues that line the cleft (Allingham et al., 2005;
Klenchin et al., 2003). Elongation of actin filaments requires an
interaction of the DNase I binding loop (SD2) of the incoming ac-
tin monomer with residues in the hydrophobic cleft of the proto-
mer at the (+)-end of the filament. However, the binding of the
macrolide tail to the (+)-end actin protomer prevents this interac-
tion (Allingham et al., 2005) and thereby blocks polymerization.
The free macrolide can also disrupt the interaction between
the D-loop and the cleft of actin monomers within the filament,
leading to severing and subsequent capping of the newly formed
(+)-end by the macrolide (Allingham et al., 2005; Tanaka et al.,
2003).
As marine macrolides are isolated from protected organisms
and typically have extremely low natural abundance, we decided
to explore their interactions and activities with actin by using fully
synthetic analogs of the tail region of reidispongiolide, with
a view to evaluating their potential as drugs for the treatment
of actin-associated disorders. Furthermore, since the tail seg-
ments of reidispongiolides A and B, sphinxolides A, B, C, and
D, halichondramide, kabiramide C, mycalolide A, and jaspisa-
mide A are structurally similar (Allingham et al., 2005; Tanaka
et al., 2003), these synthetic analogs would serve as a model
to study structure-function relationships within actin and as mo-
lecular probes for in vitro and in vivo studies of actin filament dy-
namics. A related study has been reported on simplified analogs
of the aplyronine family of marine macrolides (Hirata et al., 2006;
Kigoshi et al., 2002).5, 287–294, March 2008 ª2008 Elsevier Ltd All rights reserved 287
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Synthetic Mimetics of Actin-Binding MacrolidesFigure 1. The Structures of Reidispongiolide A and the Tail Analogs
The chemical structures of reidispongiolide A (1) and the synthetic analogs based on the tail region of reidispongiolide (labeled as 2 through to 11). Modifications
to the tail are highlighted in red. Carbon atom numbering is based on the scheme previously used for reidispongiolide (Allingham et al., 2005). The crystal structure
of reidispongiolide A bound toG-actin (Allingham et al., 2005) is shown in the top left. SD1 is shown in blue, SD3 is shown in translucent red, and reidispongiolide is
shown in CPK coloring.RESULTS AND DISCUSSION
The binding of G-actin with a library of chemically synthesized
analogs of reidispongiolide was studied by using a highly sensi-
tive fluorescence-based assay, detailed in Marriott et al. (1988).
Use of these structurally diverse analogs allows for the definition
of the interactions of specific groups on the tail with the SD1/SD3
cleft of actin and to establish the molecular determinants that
underlie the binding to actin and in vitro and in vivo inhibition of
actin filament dynamics. Such a small molecule would be
a good starting point for the development of drugs and probes
directed against actin.288 Chemistry & Biology 15, 287–294, March 2008 ª2008 Elsevier LSyntheticAnalogsof theTailRegionofReidispongiolideA
The library of analogs (2–11) of the tail region of reidispongio-
lide (1) employed in this study are shown in Figure 1. All of
these analogs feature the characteristic N-vinyl formamide
functionality of reidispongiolide, with conserved stereochemis-
try, and variation in the oxidation state at C29 and C31. The
simplest analog 2 corresponds to the C30–C37 region of reidis-
pongiolide. The more elaborate C23–C37 analogs 3, 4, 5, 6,
and 7 retain a cyclic para-methoxybenzylidene (PMP) acetal
protecting group at C23 and C25 carried over from the syn-
thetic route, while the analogs 8, 9, 10, and 11 have the liber-
ated 1,3-diol. The synthesis of these compounds, along withtd All rights reserved
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Synthetic Mimetics of Actin-Binding MacrolidesFigure 2. The Binding of Reidispongiolide and Related Compounds to Actin, Their Effect on Actin Polymerization, Depolymerization, Sever-
ing, and Competition with Other Actin-Binding Proteins
(A) Fluorescence emission spectra of 1 mM Prodan-G-actin in G-buffer and 1 mM Prodan-G-actin in G-buffer and 10 mM of compounds 1 though 11.
(B) Incubation of 0 to 50 mM 5 with 50 nM Prodan-G-actin in G-buffer.
(C) Binding of compounds 1 through 11 to Prodan-G-actin in G-buffer. The integrated emission spectra are normalized by using the integrated spectra of Prodan-
G-actin obtained in the absence of compound and in conditions where the macrolide binding site of Prodan-G-actin is fully occupied by either the compound
being titrated or halichondramide. The disassociation constants are shown in Table 1.
(D) Polymerization of 2 mM Prodan-G-actin in the absence or presence of 2 mM of either 5 or reidispongiolide (1) in polymerization buffer.
(E) Prodan-F-actin was diluted so that the total G-actin concentration was 0.1 mM, which is below the critical concentration where actin polymerization can occur.
Therefore only loss of monomers from the ()-end is possible. The rate of depolymerization in the presence of either 4 mM 5 or 0.3 mM reidispongiolide (1) is
significantly quicker than with just F-actin on its own. This is strongly suggestive of F-actin severing by 5 and reidispongiolide.
(F) Displacement of CapG from Prodan-G-actin by 5.that of reidispongiolide itself, is described elsewhere (Paterson
et al., 2007, 2008).
The Tail Region Is Sufficient for Binding to G-Actin
Stoichiometric binding of reidispongiolide to Prodan-G-actin
caused a characteristic red shift in the emission spectrum of Pro-
dan and a concomitant decrease in quantum efficiency (Tanaka
et al., 2003) compared to Prodan-G-actin alone (Figure 2A). A
similar change is observed upon stoichiometric binding of 5 to
Prodan-G-actin (Figure 2B). Since the structure of 5 is almost
identical to the C25–C37 tail region of reidispongiolide, it is likely
that tail binding is primarily responsible for the change in fluores-
cence. The same binding conditions were used to test the inter-
action of the other tail analogs shown in Figure 1, all of which
elicited far smaller spectral shifts (Figure 2A), suggesting that
these probes bound weakly to G-actin or else they did not affect
Prodan fluorescence.
The Macrolide Ring Greatly Increases the Affinity
of the Tail Region for Actin
To further detail the energetic contributions of the tail region to
actin binding, we conducted equilibrium-binding studies for all
the tail analogs, as well as for reidispongiolide itself. The intact
macrolide bound stoichiometrically to G-actin even when usingChemistry & Biology 1a Prodan-G-actin concentration of 5 nM, suggesting the Kd for
this complex, as anticipated from our earlier study (Tanaka
et al., 2003), is very low, i.e., less than 5 nM (Figure 2C, Table 1).
The highest affinity found among the tail analogs for G-actin
was for 5 with a value of 1 mM (Figure 2C, Table 1). Since reidis-
pongiolide binds to G-actin with an affinity that is at least two
orders of magnitude higher than 5, this stronger interaction
Table 1. Disassociation Constants of Reidispongiolide A and the
Reidispongiolide Tail Analogs for Prodan-G-Actin
Compound Disassociation Constant, Kd (mM)
Reidispongiolide A (1) <0.005
2 >1,000
3 100
4 24
5 1
6 26
7 200
8 71
9 >1,000
10 >1,000
11 >1,0005, 287–294, March 2008 ª2008 Elsevier Ltd All rights reserved 289
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the tail with sites on actin. The initial binding event, which occurs
with a rate of 30 s1 for the intact macrolide, is associated with
the change in Prodan emission (Tanaka et al., 2003). The fluores-
cence spectra recorded using the tail analogs in this study show
that the emission is perturbed by an interaction of the tail region
with G-actin and not by the macrolide ring, as we had postulated
by using intact macrolides (Klenchin et al., 2003; Tanaka et al.,
2003). This result was unexpected since high-resolution struc-
tures of kabirimide C-G-actin and related macrolide-actin com-
plexes (Allingham et al., 2005; Klenchin et al., 2003) show that
the tail region adopts a highly contorted conformation in the cleft
where it engages stereochemically defined interactions with res-
idues. This finding that the tail region of the macrolide binds rap-
idly to G-actin would suggest that the cleft is, in fact, rather open
and can easily accommodate the tail analog 5. These spectro-
scopic studies support our earlier conclusions (Klenchin et al.,
2003; Tanaka et al., 2003) that the binding of macrolides, includ-
ing reidispongiolide, to G-actin proceeds via two independent
and sequential interactions that begin either with occupancy of
the SD1/SD3 cleft with the tail region with an effective Kd of
71 mM followed by an interaction of the macrolide ring with the
entrance of the cleft or vice versa. The effective Kd for the in-
teraction of reidispongiolide for G-actin should therefore be de-
scribed as the product of the two Kd’s. Although we do not have
a measure of the binding of the macrolide ring alone, the data
shown in Figure 2C for reidispongiolide (1) and 8, which repre-
sents the unprotected tail region, would indicate the macrolide
ring binds to G-actin with a Kd in the micromolar range. This
two-step binding mechanism accounts for the stability of the
macrolide-G-actin complex (Tanaka et al., 2003).
Subtle Chemical Modifications within the Tail
Region Affect G-Actin Binding
The truncatedC30–C37 analog 2 does not exhibit any detectable
binding to G-actin using our experimental system, which is sen-
sitive to an upper Kd limit of 1.7 mM (corresponding to a 2%
change or shift in the Prodan signal over a 0–40 mM concentra-
tion range and using a halichondramide-determined end point).
Thus, compound 2 establishes a minimal length, being some-
where between C24 and C30 to the end of the tail, for the design
of reidispongiolide-inspired tail molecules and suggests that
some of the major determinants responsible for a strong interac-
tion of the tail with actin involve regions closer to the junctionwith
the macrolide ring.
Subtle chemical modifications within the tail region of reidis-
pongiolide greatly influenced binding to G-actin. For example,
while compound 4 differs from 5 only by a double bond at C29
to C30 (Figure 1), this change resulted in a 20-fold loss of affinity
for G-actin. The rigid double bondmost likely places a restriction
on the flexibility of the tail around the C29–C30 linkage that would
appear necessary for it to assume a twisted conformation within
the SD1/SD3 cleft (Figure 1) (Allingham et al., 2005; Klenchin
et al., 2003).
Amore dramatic perturbation to tail binding occurs when a hy-
droxyl group is placed at C29 as in 3, which results in a decrease
in the dissociation constant by 100-fold compared to 5 (Fig-
ure 2C, Table 1). Interestingly, the reduction of the ketone at
C31 in 3 to the secondary alcohol in compound 6 improves the290 Chemistry & Biology 15, 287–294, March 2008 ª2008 Elsevier Ldissociation constant from 100 mM to 26 mM, respectively. An
inspection of high-resolution structures of macrolides bound to
G-actin (Allingham et al., 2005; Klenchin et al., 2003) shows
that the ketone at C31 and the proton on C29 are both directed
away from the cleft toward the solvent and do not engage in di-
rect interactions with groups on G-actin. Therefore, we specu-
late that the dramatic attenuation in the Kd for the G-actin com-
plex observed for 3 compared to 5 is a consequence of a new
and stronger dipolar interaction of the hydroxyl at C29 with a res-
idue on the cleft that directs the remaining stretch of the tail away
from its normal binding site. Alternatively, the C29-hydroxyl and
the ketone of 3 could form an intramolecular hydrogen bond that
impairs conformational mobility and reduces the affinity of the
tail for actin. The improved binding of 6 versus 3 (26 mM versus
100 mM, respectively) may reflect a greater conformational free-
dom around the C30-C31-C32 bonds in 6 and recovery of inter-
actions between the tail and the cleft. Acetylation of the two sec-
ondary alcohol groups of 6 was used to generate 7; the
increased volume and hydrophobicity of the acetyl groups evi-
dently affected specific interactions between the tail and the cleft
since the Kd for the G-actin complex of compound 7 compared
to 6 increased by almost an order of magnitude to 200 mM.
On the basis of the binding studies using the complete set of
tail analogs, it is likely that specific hydrophobic and dipolar
interactions close to the macrolide ring-tail junction are required
for strong binding to G-actin and that the presence of additional
polar groups or a restriction of tail flexibility greatly impedes
complex formation. These results also suggest that substituent
groups along the tail are inimitable, a view that is supported by
the conserved structure and stereochemistry of the tail region
of known macrolides (Allingham et al., 2005; Klenchin et al.,
2003; Tanaka et al., 2003).
Small Apolar Groups Appended to the Tail Mimic
the Macrolide Ring
The PMP acetal protecting group was removed from com-
pounds 3, 4, 5, and 7 to form the corresponding 1,3-diols 10,
9, 8, and 11, respectively (Figure 1). Removal of the aromatic
PMP group greatly decreased the affinity of these compounds
for G-actin, by some 71-fold in the case of 5 (Figure 2C, Table
1). The poor binding of tail analogs lacking the PMP group sug-
gests that this acetal protecting group provides additional inter-
actions with actin that stabilize the complex. An inspection of the
high-resolution structures of actin-macrolide complexes would
position the PMP group at the entrance of the SD1/SD3 cleft.
We suggest therefore that the PMP group mimics in small part
the contributions of the macrolide ring to the actin complex.
These results and earlier studies (Allingham et al., 2005; Tanaka
et al., 2003) support the idea that the complex between actin and
macrolide natural products involves two independent interac-
tions involving the tail and ring regions. The effective dissociation
constant of the complex would therefore be described by
the product of the Kd’s for the tail and macrolide ring. Thus, in
the case of the G-actin-reidispongiolide complex, the Kd for
the macrolide ring alone would be at least 70 mM, the quotient
of the Kd’s for reidispongiolide and 8 (5 nM/71 mM). Clearly,
having different polar and hydrophobic groups attached to this
region could be used to modulate the affinity of the tail region
for actin. Furthermore, by replacing the PMP group withtd All rights reserved
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Synthetic Mimetics of Actin-Binding Macrolidestetramethylrhodamine (a fluorophore known to have a slight
affinity for the SD1/SD3 hydrophobic patch on actin; Otterbein
et al., 2001) or a targeting ligand, it should be possible to gener-
ate a family of high affinity optical sensors to image the distribu-
tion of (+)-ends in live cells (Choidas et al., 1998; Petchprayoon
et al., 2005) or else to target the drug to specific tumor cells.
Tail Analogs Reduce the Rate of Actin Polymerization
Salt-induced polymerization of Prodan-G-actin is accompanied
by a blue shift in the Prodan emission spectra and an increase
in the quantum yield that can be exploited to measure rates of
actin polymerization (Marriott et al., 1988; Tanaka et al., 2003).
As expected, addition of a stoichiometric level of reidispongio-
lide inhibited actin polymerization (Figure 2D). Similar results
were found for several tail analogs although with a reduced effi-
cacy that scaled with their effective Kd for G-actin.
Compounds exhibiting a high affinity for G-actin, such as rei-
dispongiolide and 5, can sequester G-actin molecules to reduce
the free G-actin concentration leading to a concomitant de-
crease in the rate and extent of actin polymerization. For exam-
ple, no actin polymerization was observed for 2 mM Prodan-G-
actin in the presence of 2 mM reidispongiolide (Figure 2D), which
essentially reduced the concentration of free G-actin to <5 nM or
more than 40 times lower than the critical concentration for po-
lymerization (Marriott et al., 1988). The rate for the polymerization
of 2 mMProdan-G-actin in the presence of 2 mMof 5 on the other
hand was 47% that of the control sample (Figure 2D), which
given a Kd of 1 mM, would reduce the free concentration of G-
actin to 1 mM. Clearly, sequestration by 5 is not the sole mech-
anism for the inhibition of actin polymerization, since at this
concentration compound 5 would also cap filament growth by
binding to the protomer at the (+)-end of the filament and sever
nascent filaments (next section).
Only the Tail Region of Reidispongiolide Is Required
for Filament Severing
The rate of actin depolymerization via loss of protomers from the
(+) and ()-ends of a filament can be studied by rapidly diluting
a concentrated solution of F-actin to 0.1 mM, i.e., below the crit-
ical concentration for actin polymerization (Marriott et al., 1988).
Under these conditions, tail compounds added to the diluted
F-actin that increase the rate of depolymerization compared to
the control sample must do so by severing filaments. This prop-
erty is clearly demonstrated for 2 mMof compound 5 or reidispon-
giolide in Figure 2E, which shows a plot of the amount of Prodan-
F-actin versus time in the absence or presence of the drug. Similar
results were obtained when using F-actin at 2 mM, ten times the
critical concentration for actin polymerization (data not shown).
No evidence of filament severing was found by using other tail
derivatives up to 4 mM, although we anticipate they would exhibit
a severing activity when used closer to their own Kd concentra-
tion. Studies using analogs of the macrolide aplyronine A also
suggest that the actin-deploymerizing activity was mediated by
the aliphatic tail (Hirata et al., 2006; Kigoshi et al., 2002).
Tail Regions of Reidispongiolide Bind to the (+)-End
of the Actin Filament
CapG is a Ca2+-activated actin-binding protein that forms com-
plexeswith the (+)-endofF-actinwith reportedKdvaluesbetweenChemistry & Biology 125–100 nM (Southwick and DiNubile, 1986; Tanaka et al., 2003;
Zhang et al., 2006). The fluorescence emission spectrum of Pro-
dan-G-actin in theCapGcomplex is remarkably similar to that ob-
served for F-actin, suggesting a similar buried environment for
Prodan (Tanaka et al., 2003). This characteristic fluorescence
spectrum was used to show that reidispongiolide and the tail an-
alogs compete for the samesite onG-actin asCapG. Thus, by us-
ing stoichiometric binding conditions, we found that 5 (20 mM) ef-
fectively displaced 100 nM CapG from its complex with 25 nM
Prodan-G-actin as evidenced by a red-shifted Prodan spectrum
that is similar to that found in the complex of 5 with Prodan-G-
actin (Figure 2F). Stoichiometric levels of CapG were also found
to displace 5 from its complex with Prodan-G-actin (Figure 2F).
These results areconsistentwithour earlier studywithkabiramide
C and with later crystallographic analyses of G-actin complexes
with macrolides (Klenchin et al., 2003) and (+)-end binding pro-
teins (Dominguez, 2004) that show the tail region of themacrolide
and a long a helix within the capping protein bind along the cleft
that forms between SD1 and SD3 (Allingham et al., 2005).
Cell Studies
Treatment of rat bladder epithelial cells (NBT-II) with reidispon-
giolide at concentrations >100 nM produces similar effects as
those generated by kabiramide C (Tanaka et al., 2003) with rapid
disruption of actin-rich adherens junctions, breakdown of cell-
cell contacts, polyploidy, and eventually apoptosis (Figure 3).
The strong and long-livedG-actin complex, together with its sev-
ering and (+)-end capping activity, allows reidispongiolide to ac-
cumulate in the cell to significant levels even with a bathing con-
centration of 10 nM. This occurs in spite of high concentrations
(>50 mM) of endogenous G-actin binding proteins, such as pro-
filin and thymosin b4, which bind to G-actin about 100-fold
less tightly compared to reidispongiolide (Goldschmidt-Cler-
mont et al., 1990, 1992). None of the reidispongiolide tail analogs
affected cell morphology or viability when used below 1 mM, nor
did theweakly binding compounds 2, 3, 8, 9, 10, and 11 at a bath-
ing concentration of 10 mM. On the other hand, prolonged expo-
sure (16 hr) of NBT-II cells to compounds 4 and 6 at 10 mM
caused breakdown of adherens junctions, as evidenced by the
loss of cell-cell contacts (Figures 3J and 3K). Compound 5, as
expected based on the equilibrium binding studies, induced dra-
matic morphologic changes and cytotoxicity to NBT-II cells
when added to the medium at 10 mM (Figure 3I), and even at
1 mM (Figure 3H), there was evidence of a breakdown in adhe-
rens junctions. We argue that the cytotoxicity of the tail analogs
scales with the dissociation constant of their complex with
G-actin. Therefore, if all the tail compounds are membrane per-
meable, then only a tiny fraction of cell actin would exist in a com-
plex for the very weakly binding tail analogs (2, 3, 8, 9, 10, 11).
Finally, it was surprising to find that compound 7 was also
effective in breaking cell-cell contacts in NBT-II epithelia, since
its complex with G-actin has a poor Kd of 200 mM. The observed
cytotoxicitymost likely arises by hydrolysis of the two ester groups
in 7 by nonspecific cellular esterases that would generate 6,
improving the affinity for G-actin by almost 8-fold. It is also
significant that ulapualide A and aplyronine A also harbor large
ester-linked hydrophobic groups in their tail region that should re-
duce their affinity for actin. In fact, ulapualide A is known to exhibit
weak binding to actin that compromised assignment of the atoms5, 287–294, March 2008 ª2008 Elsevier Ltd All rights reserved 291
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Synthetic Mimetics of Actin-Binding MacrolidesFigure 3. The Effect of Reidispongiolide and Tail Analogs 4, 5, 6, and 7 on Cultured NBT-II Cells
Micrographs of (A) untreated NBT-II epithelial cells and NBT-II cells treated with: (B) 10 nM, (C) 100 nM, (D) 1 mM, and (E) 10 mM reidispongiolide; (F) 10 nM, (G)
100 nM, (H) 1 mM, and (I) 10 mM tail analog 5; (J) 10 mM tail analog 4; (K) 10 mM tail analog 6; and (L) 10 mM tail analog 7.in the terminal region of the macrolide tail in the high-resolution
structure of the complex (Allinghamet al., 2004). If thede-esterified
tails of ulapualide and othermacrolideswere found to be the active
forms of the drug in cells, then it would be prudent to conduct
future structural and binding studies with these modified drugs.
SIGNIFICANCE
This study has shown that the G-actin-binding and actin-fil-
ament-severing activity observed for marine organism-de-
rived macrolides such as kabiramide C (Tanaka et al.,
2003) and reidispongiolide (Allingham et al., 2005; D’Auria
et al., 1994) reside in the tail region of the molecule. We de-
fined a minimum length of the tail (in 2) for actin binding of
1 nm and showed that the affinity of the full-length tail an-
alogs was attenuated by reducing conformational flexibility
within the tail or by introducing a polar hydroxyl group at
C29 (as in 3). The affinity of the tail region for actin, as well
as the severing activity, improved dramatically on attaching
a small hydrophobic protecting group (PMP) to the C23 and292 Chemistry & Biology 15, 287–294, March 2008 ª2008 Elsevier LC25 hydroxyls. We argued that the aromatic acetal protect-
ing group mimics the action of the macrolide ring by provid-
ing additional binding energy to the complex through a
separate and sequential interaction (Allingham et al., 2005;
Tanaka et al., 2003). This finding suggests that the affinity
of the tail for actin could be further improved by appending
larger hydrophobic groups. Attractive candidates would be
tetramethylrhodamine,whichwould also serve as asensitive
optical probe of the barbed end in cells (Choidas et al., 1998;
Petchprayoon et al., 2005), and specific ligands for receptor
proteins that could be used to deliver the cytotoxic tail to
specific tumor cells or to restrict the tail to serum for control
of serum actin following stroke or to reduce the viscosity of
sputum, produced by inflammatory lung diseases.
EXPERIMENTAL PROCEDURES
Reidispongiolide and Tail Analogs
Reidispongiolide (1) and its tail analogs 2–11 were prepared by the synthetic
routes reported by Paterson et al. (2007, 2008). The compounds were
dissolved in DMSO to a concentration of 2 mM and stored at 20C.td All rights reserved
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Byusingprotocols that havebeenpreviouslydescribedbyMarriott et al. (1988),
G-actin was purified from chicken skeletal muscle and subsequently labeled
with the thiol-reactive probe Acrylodan (Invitrogen). The labeling of actin with
Prodan has been reported not to affect the functional activity of actin (Marriott
et al., 1988; Roy et al., 2001; Zechel, 1993). Protein concentrations were mea-
sured by the Bradford assay (Bradford, 1976) and labeling efficiencies mea-
sured with an UV-1601PC UV-Visible Spectrophotometer (Shimadzu), the ex-
tinction coefficient of actin at 290 nm (2.6 3 104 M1 cm1) (Gordon et al.,
1976) and the extinction coefficient of Prodan at 375 nm (1.853 104M1 cm1)
(Weber and Farris, 1979) and at 290 nm (1.853 104 M1 cm1) (Marriott et al.,
1988). Labeling efficiencies were typically around 30%.
Binding of Reidispongiolide and Its Analogs to Prodan-G-Actin
Red shifts in the fluorescence emission spectrum of Prodan-G-actin, which
occur upon binding macrolides, were measured with an Aminco-Bowman
Series 2 (AB2) Fluorimeter (ThermoSpectronic). For the preliminary binding ex-
periments, the emission spectra of 1 mMProdan-G-actin in G-buffer (2mMTris
[pH 8], 0.2 mM ATP, 0.2 mM CaCl2, 0.2 mM DTT) in the presence of 10 mM
reidispongiolide, 10 mM of a compound derived from the tail region of reidis-
pongiolide (compounds 2 through 11) or in the absence of any additional com-
pound were measured. These samples were excited at 385 nm (4 nm band-
pass, 0 polarization), and the emission spectra measured from 400 nm to
650 nm (4 nm bandpass, 54.7 polarization).
Tomeasure the disassociation constants, the emission spectra of G-actin, in
G-buffer, in the presence of a range of compound concentrations were mea-
sured. For compounds 2 to 11, 50 nM Prodan-G-actin was used, and 5 nM
Prodan-G-actin was used when measuring the affinity for reidispongiolide.
Compound concentrations ranged from 0–400 nM for reidispongiolide A and
0–40 mM for the macrolide-tail-derived compounds. Concentrations of com-
pounds greater than 40 mM were prohibited due to the accompanying high
DMSO concentration, which would lead to denaturation of Prodan-G-actin.
For those compounds where 100% binding to Prodan-G-actin was not possi-
ble, the end-point spectrum was generated by measuring 50 nM G-actin in
G-buffer with a saturating concentration of themacrolide halichondramide (Ta-
naka et al., 2003). These samples were excited at 385 nm (8 nm bandpass,
0 polarization), and the emission spectra measured from 410 nm to 650 nm
(16 nm bandpass, 54.7 polarization).
For the binding of compounds 2 through to 11, the raw emission spectra
were integrated with the AB2 software (ThermoSpectronic). Due to the low in-
tensity of the emission spectra produced with 5 nM Prodan-G-actin, the water
Raman peak at440 nm had to be subtracted from the reidispongiolide spec-
tra before integrating. Integrated spectra were normalized between the values
obtained in the absence and presence of a saturating concentration of macro-
lide or tail analog. Disassociation constants were calculated by curve fitting to
the normalized integrated spectra.
Polymerization of Actin in the Presence of Reidispongiolide
and Its Derivatives
The time course of the polymerization of 2 mM G-actin in G-buffer, with either
2 mM reidispongiolide, tail analog, or no additional compound present, was fol-
lowed with an AB2 fluorimeter. Two millimolars MgCl2 and 100 mM KCl were
added to the reaction to initiate polymerization immediately before the sam-
ples were inserted into the fluorimeter. Samples were excited at 385 nm
(4 nm bandwidth, 0 polarization), and the emission was measured at 465 nm
(4 nm bandwidth, 54.7 polarization).
Severing Assay in the Presence of Actin Polymerization
2.2 mM G-actin was allowed to polymerize overnight in polymerization buffer
(2 mM Tris [pH 8], 0.2 mM ATP, 0.2 mM CaCl2, 0.2 mM DTT, 2 mM MgCl2,
100 mM KCl) at 4C. The polymerized actin was diluted, to produce a total
monomer concentration of 2 mM, in polymerization buffer that contained
2–4 mM reidispongiolide, 2–4 mM tail analog, or no additional compound. Sev-
ering and depolymerization of the F-actin was followed with an AB2 fluorimeter
with the settings used to measure actin polymerization (see above).Chemistry & Biology 1Severing/Depolymerization Assay in the Absence of Further
Actin Polymerization
Two micromolars G-actin was allowed to polymerize overnight in polymeriza-
tion buffer at 4C. The polymerized actin was diluted, to produce a total mo-
nomer concentration of 0.1 mM, in polymerization buffer that contained 4 mM
reidispongiolide, 4 mM of 5 or no additional compound. Severing and depoly-
merization of the F-actin was followed with an AB2 fluorimeter under the same
settings as used to measure actin polymerization (see above).
CapG Competition Binding Assay
CapG was purified, from bacteria expressing CapG cDNA, as previously out-
lined in Tanaka et al. (2003). CapG protein was stored as a glycerol stock at
20C. Before use, glycerol stocks of CapG were dialyzed overnight against
G-buffer, at 4C, and protein concentrations measured by the Bradford assay
(Bradford, 1976).
To measure the competition of the two compounds for actin, fluorescence
emission spectra were taken of: (1) G-actin in G-buffer; (2) G-actin and the
compound to be displaced in G-buffer; (3) G-actin and the displacing com-
pound in G-buffer; (4) G-actin, the displaced compound, and the displacing
compound in G-buffer. The compound to be displaced was present at approx-
imately its Kd for G-actin, the displacing compound was present at 20 times
its Kd for G-actin, and G-actin was present at the same concentration as either
the displaced or displacing compound, whichever was lower. For example,
when displacing CapG from G-actin with compound 5, CapG and G-actin
were at 25 nM, and 5 was at 20 mM. The emission spectra were taken from
410 to 650nm (16 nmbandwidth, 54.7 polarization) by using anAB2 fluorimeter
with excitation at 385 nm (8 nm bandwidth, 0 polarization).
Cell Assays
NBT-II cells (ATCC) were cultured as previously described by Choidas et al.
(1998). Cells were treated with the compounds overnight before being imaged
with a phase-contrast microscope.
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